News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment in children news

Show

From To
HIV treatment in children
Lopinavir Bests Nevirapine for HIV in Kids

For treating children infected with HIV, the protease inhibitor combination of lopinavir/ritonavir (Kaletra) outperforms the non-nucleoside reverse transcriptase inhibitor nevirapine (Viramune), researchers suggested here.

Published
09 March 2012
From
MedPage Today HIV/AIDS
HIV treatment in children
Controversy regarding strategic treatment interruptions in young children who start ART during infancy

Two studies generated conflicting data and rather mixed messages about whether it is safe or advisable to strategically interrupt treatment in children (STIC) who have initiated antiretroviral

Published
09 March 2012
By
Theo Smart
Child developmental issues
Time HIV Tx Starts Has No Impact on IQ

Neurological development of children infected with HIV does not appear to be influenced by the decision on when to start antiretroviral therapy, researchers said here.

Published
08 March 2012
From
MedPage Today
Lipodystrophy
Lipoatrophy common in children receiving d4T in South Africa

Exposure to d4T (stavudine) among young children in sub-Saharan Africa remains the greatest risk factor for lipodystrophy syndrome (that includes lipoatrophy and lipohypertrophy) for a significant proportion of

Published
07 March 2012
By
Carole Leach-Lemens
HIV treatment in children
Etravirine proves safe in children and adolescents in pilot trial

Etravirine, one of the newer nonnucleoside reverse transcriptase inhibitors (NNRTIs), was well tolerated in a pilot trial that enrolled children and adolescents. Concentrations achieved with a dose of 5.2 mg/kg were generally equivalent to those attained by adults taking the standard dose.

Published
21 February 2012
From
International AIDS Society
HIV treatment in children
U.S. Food and Drug Administration Approves New Formulations of Viread(R) for Use by Children Living With HIV

(BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved Viread(R) (tenofovir disoproxil fumarate) in combination with other antiretroviral agents for the treatment of HIV-1

Published
19 January 2012
From
CNBC
HIV treatment in children
Europeans find high prevalence of lipodystrophy in HIV-positive children

A European study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes has found a high prevalence of body fat changes and

Published
05 January 2012
By
Michael Carter
HIV treatment in children
US approval for paediatric use of raltegravir, new chewable tablet also gets the go-ahead

Drug regulatory authorities in the US have approved raltegravir (Isentress) for the treatment of HIV-positive children. In addition, chewable raltegravir tablets in 100mg scored and 25 mg formulations

Published
05 January 2012
By
Michael Carter
HIV treatment in children
ART improves impact of therapeutic feeding in malnourished infants with HIV

HIV-infected malnourished children in urban Malawi who got ART within three weeks of therapeutic feeding were more likely to recover nutritionally (86% compared to 60%, p<0.01) and gained

Published
04 January 2012
By
Carole Leach-Lemens
HIV treatment in children
Updated information about Prezista (darunavir): oral suspension and labeling changes

The Food and Drug Administration approved an oral suspension formulation of Prezista (darunavir). Prezista is now available as a 100 mg/mL oral suspension.

Published
22 December 2011
From
EATG / FDA
← Prev1...34567...13Next →

Filter by country